Discover
ACTU
Actuate Therapeutics Inc
1.54
1 x 1.40
200 x 1.68
bid
ask
+
0.14
10.00%
08:52 AM
timesize
| Ytd | -74.84% | |
| 1y | -72.79% |
1.36
day range
1.50
1.16
52 week range
9.22
| Open | 1.36 | Prev Close | 1.40 | Low | 1.36 | High | 1.50 | Mkt Cap | 33.50M |
| Vol | 2.30K | Avg Vol | 259.02K | EPS | -0.97 | P/E | -1.44 | Forward P/E | N/A |
| Beta | 0.67 | Short Ratio | 0.49 | Inst. Own | 53.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.05 | 200-d Avg | 4.30 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 5.71M | ||
| Research and Development Expense | 2.57M | ||
| Selling, General and Administrative Expense | 3.14M | ||
| Operating Income | -5.71M | ||
| Interest Expense | 5.06K | ||
| Net Income | -5.63M | ||
| Net Income Common Stock | -5.63M | ||
| Net Income Common Stock (USD) | -5.63M | ||
| Consolidated Income | -5.63M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -5.62M | ||
| Earning Before Interest & Taxes (USD) | -5.62M | ||
| Weighted Average Shares | 23.54M | ||
| Weighted Average Shares Diluted | 23.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.13M | ||
| Cash and Equivalents (USD) | 8.13M | ||
| Current Assets | 8.52M | ||
| Total Assets | 8.91M | ||
| Current Liabilities | 4.72M | ||
| Total Liabilities | 5.13M | ||
| Accumulated Retained Earnings (Deficit) | -160.23M | ||
| Shareholders Equity | 3.78M | ||
| Shareholders Equity (USD) | 3.78M | ||
| Assets Non-Current | 391.84K | ||
| Liabilities Non-Current | 404.99K | ||
| Trade and Non-Trade Payables | 1.61M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -8.09K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.03M | ||
| Issuance (Purchase) of Equity Shares | 519.62K | ||
| Net Cash Flow from Operations | -5.02M | ||
| Share Based Compensation | 1.36M | ||